79.49

3.52% -2.90

Nuvalent Inc (NUVL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché NUVL Giù? Forum Previsione

Precedente Chiudi:

$82.39

Aprire:

$83.16

Volume 24 ore:

319.93K

Relative Volume:

0.73

Capitalizzazione di mercato:

$5.65B

Reddito:

Utile/perdita netta:

$-224.29M

Rapporto P/E:

-22.91

EPS:

-3.47

Flusso di cassa netto:

$-153.27M

1 W Prestazione:

+2.00%

1M Prestazione:

+1.55%

6M Prestazione:

-3.83%

1 anno Prestazione:

-3.68%

Intervallo 1D:

$79.34

$83.63

Intervallo di 1 settimana:

$77.90

$83.63

Portata 52W:

$61.80

$113.51

Nuvalent Inc Stock (NUVL) Company Profile

Nome

Nuvalent Inc

Settore

Healthcare (1169)

Industria

Biotechnology (678)

Telefono

508-446-2272

Indirizzo

ONE BROADWAY, 14TH FLOOR, CAMBRIDGE

Dipendente

127

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

NUVL's Discussions on Twitter

Confronta NUVL con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NUVL Nuvalent Inc	79.49	5.65B	0	-224.29M	-153.27M	-3.47
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Nuvalent Inc Stock (NUVL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-30	Iniziato	H.C. Wainwright	Buy
2024-10-24	Iniziato	UBS	Neutral
2024-08-29	Iniziato	Barclays	Overweight
2024-04-17	Iniziato	Jefferies	Buy
2024-04-01	Aggiornamento	Leerink Partners	Market Perform → Outperform
2024-02-28	Ripresa	Guggenheim	Buy
2024-02-23	Iniziato	Robert W. Baird	Outperform
2023-09-27	Iniziato	Stifel	Buy
2023-08-08	Iniziato	SVB Securities	Market Perform
2023-07-24	Iniziato	Guggenheim	Buy
2023-01-18	Iniziato	Wedbush	Outperform
2022-06-24	Iniziato	BMO Capital Markets	Outperform

Mostra tutto

Nuvalent Inc Borsa (NUVL) Ultime notizie

Feb 21, 2025

Nuvalent CEO sells stock worth over $2.1 million By Investing.com - Investing.com South Africa

Feb 21, 2025

Feb 20, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives $112.36 Consensus Target Price from Analysts - MarketBeat

Feb 14, 2025

Feb 13, 2025

Q1 Earnings Estimate for Nuvalent Issued By Leerink Partnrs - MarketBeat

Feb 13, 2025

abrdn plc Buys 9,241 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat

Feb 13, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives $112.36 Consensus PT from Brokerages - Defense World

Feb 13, 2025

Feb 11, 2025

10 Mid-Cap Stocks Insiders Are Selling Recently - Insider Monkey

Feb 11, 2025

Why Insiders Are Selling Nuvalent, Inc. (NUVL) Recently - Insider Monkey

Feb 11, 2025

What is Leerink Partnrs' Forecast for Nuvalent Q2 Earnings? - MarketBeat

Feb 11, 2025

Feb 08, 2025

KBC Group NV Boosts Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Feb 08, 2025

What is Leerink Partnrs’ Forecast for Nuvalent Q2 Earnings? - Defense World

Feb 08, 2025

Feb 07, 2025

Long Term Trading Analysis for (NUVL) - Stock Traders Daily

Feb 07, 2025

Feb 05, 2025

Nuvalent (NASDAQ:NUVL) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Feb 05, 2025

Feb 04, 2025

The Potential Rise in the Price of Nuvalent Inc (NUVL) following insiders activity - Knox Daily

Feb 04, 2025